No takes yet. Share an insight, caveat, or question.
Spatial multiomics reveals immune responses and biomarkers in the bone marrow microenvironment of NPM1-mutant AML patients, suggesting key treatment insights.
Zeis et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: